Suzanne N. Avery
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Suzanne N. Avery has a total of 122 co-authors. Here are the top co-authors by number of shared publications:
- Jennifer Urbano Blackford
Munroe-Meyer Institute, University of Nebraska Medical Center, Omaha, NE, USA
20 shared publications Stephan Heckers
Department of Psychiatry and Behavioral Sciences, Vanderbilt University Medical Center, Nashville, USA
9 shared publications- Jacqueline Alexandra Clauss
Department of Psychiatry, Massachusetts General Hospital, Boston, MA
8 shared publications - Stephan Heckers
Department of Psychiatry and Behavioral Sciences, Vanderbilt University Medical Center, Nashville, USA
8 shared publications Kristan Armstrong
Department of Psychiatry and Behavioral Sciences, Vanderbilt University Medical Center, Nashville, USA
7 shared publications- Baxter P. Rogers
Department of Psychiatry and Behavioral Sciences, Vanderbilt University Medical Center, Nashville, USA
5 shared publications
Latest Publications
- Open Access
- 4 July 2025
- Published by Elsevier in Journal of the American Academy of Child & Adolescent Psychiatry
- Vol. 65 (4) , 577-604
Structural Brain Correlates of Childhood Inhibited Temperament: An ENIGMA-Anxiety Mega-Analysis
- 4 July 2025
- Published by Elsevier in Journal of the American Academy of Child & Adolescent Psychiatry
- Vol. 65 (4) , 577-604
Open AccessStructural Brain Correlates of Childhood Inhibited Temperament: An ENIGMA-Anxiety Mega-Analysis
- Open Access
- 31 January 2024
- Published by Springer Nature in Translational Psychiatry
- Vol. 14 (1) , 1-8
Smaller anterior hippocampal subfields in the early stage of psychosis
Hippocampal volume is smaller in schizophrenia, but it is unclear when in the illness the changes appear and whether specific regions (anterior, posterior) and subfields (CA1, CA2/3, dentate gyrus, subiculum) are affected. Here, we used a high-resolution T2-weighted sequence specialized for imaging hippocampal subfields to test the hypothesis that anterior CA1 volume is lower in early psychosis. We measured subfield volumes across hippocampal regions in a group of 90 individuals in the early stage of a non-affective psychotic disorder and 70 demographically similar healthy individuals. We observed smaller volume in the anterior CA1 and dentate gyrus subfields in the early psychosis group. Our findings support models that implicate anterior CA1 and dentate gyrus subfield deficits in the mechanism of psychosis.
- 31 January 2024
- Published by Springer Nature in Translational Psychiatry
- Vol. 14 (1) , 1-8
Open AccessSmaller anterior hippocampal subfields in the early stage of psychosis
Hippocampal volume is smaller in schizophrenia, but it is unclear when in the illness the changes appear and whether specific regions (anterior, posterior) and subfields (CA1, CA2/3, dentate gyrus, subiculum) are affected. Here, we used a high-resolution T2-weighted sequence specialized for imaging hippocampal subfields to test the hypothesis that anterior CA1 volume is lower in early psychosis. We measured subfield volumes across hippocampal regions in a group of 90 individuals in the early stage of a non-affective psychotic disorder and 70 demographically similar healthy individuals. We observed smaller volume in the anterior CA1 and dentate gyrus subfields in the early psychosis group. Our findings support models that implicate anterior CA1 and dentate gyrus subfield deficits in the mechanism of psychosis.
- Open Access
- 13 October 2023
- Published by Springer Nature in Neuropsychopharmacology
- Vol. 49 (4) , 681-689
Modulation of hippocampal activity in schizophrenia with levetiracetam: a randomized, double-blind, cross-over, placebo-controlled trial
Hippocampal hyperactivity is a novel pharmacological target in the treatment of schizophrenia. We hypothesized that levetiracetam (LEV), a drug binding to the synaptic vesicle glycoprotein 2 A, normalizes hippocampal activity in persons with schizophrenia and can be measured using neuroimaging methods. Thirty healthy control participants and 30 patients with schizophrenia (28 treated with antipsychotic drugs), were randomly assigned to a double-blind, cross-over trial to receive a single administration of 500 mg oral LEV or placebo during two study visits. At each visit, we assessed hippocampal function using resting state fractional amplitude of low frequency fluctuations (fALFF), cerebral blood flow (CBF) with arterial spin labeling, and hippocampal blood-oxygen-level-dependent (BOLD) signal during a scene processing task. After placebo treatment, we found significant elevations in hippocampal fALFF in patients with schizophrenia, consistent with hippocampal hyperactivity. Additionally, hippocampal fALFF in patients with schizophrenia after LEV treatment did not significantly differ from healthy control participants receiving placebo, suggesting that LEV may normalize hippocampal hyperactivity. In contrast to our fALFF findings, we did not detect significant group differences or an effect of LEV treatment on hippocampal CBF. In the context of no significant group difference in BOLD signal, we found that hippocampal recruitment during scene processing is enhanced by LEV more significantly in schizophrenia. We conclude that pharmacological modulation of hippocampal hyperactivity in schizophrenia can be studied with some neuroimaging methods, but not others. Additional studies in different cohorts, employing alternate neuroimaging methods and study designs, are needed to establish levetiracetam as a treatment for schizophrenia.
- 13 October 2023
- Published by Springer Nature in Neuropsychopharmacology
- Vol. 49 (4) , 681-689
Open AccessModulation of hippocampal activity in schizophrenia with levetiracetam: a randomized, double-blind, cross-over, placebo-controlled trial
Hippocampal hyperactivity is a novel pharmacological target in the treatment of schizophrenia. We hypothesized that levetiracetam (LEV), a drug binding to the synaptic vesicle glycoprotein 2 A, normalizes hippocampal activity in persons with schizophrenia and can be measured using neuroimaging methods. Thirty healthy control participants and 30 patients with schizophrenia (28 treated with antipsychotic drugs), were randomly assigned to a double-blind, cross-over trial to receive a single administration of 500 mg oral LEV or placebo during two study visits. At each visit, we assessed hippocampal function using resting state fractional amplitude of low frequency fluctuations (fALFF), cerebral blood flow (CBF) with arterial spin labeling, and hippocampal blood-oxygen-level-dependent (BOLD) signal during a scene processing task. After placebo treatment, we found significant elevations in hippocampal fALFF in patients with schizophrenia, consistent with hippocampal hyperactivity. Additionally, hippocampal fALFF in patients with schizophrenia after LEV treatment did not significantly differ from healthy control participants receiving placebo, suggesting that LEV may normalize hippocampal hyperactivity. In contrast to our fALFF findings, we did not detect significant group differences or an effect of LEV treatment on hippocampal CBF. In the context of no significant group difference in BOLD signal, we found that hippocampal recruitment during scene processing is enhanced by LEV more significantly in schizophrenia. We conclude that pharmacological modulation of hippocampal hyperactivity in schizophrenia can be studied with some neuroimaging methods, but not others. Additional studies in different cohorts, employing alternate neuroimaging methods and study designs, are needed to establish levetiracetam as a treatment for schizophrenia.
- Open Access
- 25 October 2022
- Published by Elsevier in Biological Psychiatry Global Open Science
- Vol. 3 (4) , 979-989
Hippocampal Network Dysfunction in Early Psychosis: A 2-Year Longitudinal Study
- 25 October 2022
- Published by Elsevier in Biological Psychiatry Global Open Science
- Vol. 3 (4) , 979-989
Open AccessHippocampal Network Dysfunction in Early Psychosis: A 2-Year Longitudinal Study
- 1 August 2022
- Published by Elsevier in Biological Psychiatry: Cognitive Neuroscience and Neuroimaging
- Vol. 7 (8) , 782-792
Development of Thalamocortical Structural Connectivity in Typically Developing and Psychosis Spectrum Youths
- 1 August 2022
- Published by Elsevier in Biological Psychiatry: Cognitive Neuroscience and Neuroimaging
- Vol. 7 (8) , 782-792
Development of Thalamocortical Structural Connectivity in Typically Developing and Psychosis Spectrum Youths
- Open Access
- 13 June 2022
- Published by Elsevier in Journal of the American Academy of Child & Adolescent Psychiatry
- Vol. 61 (9) , 1182-1188
Structural Brain Correlates of Childhood Inhibited Temperament: An ENIGMA-Anxiety Mega-analysis
- 13 June 2022
- Published by Elsevier in Journal of the American Academy of Child & Adolescent Psychiatry
- Vol. 61 (9) , 1182-1188
Open AccessStructural Brain Correlates of Childhood Inhibited Temperament: An ENIGMA-Anxiety Mega-analysis
- Open Access
- 5 January 2021
- Published by Springer Nature in Translational Psychiatry
- Vol. 11 (1) , 1-10
Stable habituation deficits in the early stage of psychosis: a 2-year follow-up study
Neural habituation, the decrease in brain response to repeated stimuli, is a fundamental, highly conserved mechanism that acts as an essential filter for our complex sensory environment. Convergent evidence indicates neural habituation is disrupted in both early and chronic stages of schizophrenia, with deficits co-occurring in brain regions that show inhibitory dysfunction. As inhibitory deficits have been proposed to contribute to the onset and progression of illness, habituation may be an important treatment target. However, a crucial first step is clarifying whether habituation deficits progress with illness. In the present study, we measured neural habituation in 138 participants (70 early psychosis patients (<2 years of illness), 68 healthy controls), with 108 participants assessed longitudinally at both baseline and 2-year follow-up. At follow-up, all early psychosis patients met criteria for a schizophrenia spectrum disorder (i.e., schizophreniform disorder, schizophrenia, schizoaffective disorder). Habituation slopes (i.e., rate of fMRI signal change) to repeated images were computed for the anterior hippocampus, occipital cortex, and the fusiform face area. Habituation slopes were entered into a linear mixed model to test for effects of group and time by region. We found that early psychosis patients showed habituation deficits relative to healthy control participants across brain regions, and that these deficits were maintained, but did not worsen, over two years. These results suggest a stable period of habituation deficits in the early stage of schizophrenia.
- 5 January 2021
- Published by Springer Nature in Translational Psychiatry
- Vol. 11 (1) , 1-10
Open AccessStable habituation deficits in the early stage of psychosis: a 2-year follow-up study
Neural habituation, the decrease in brain response to repeated stimuli, is a fundamental, highly conserved mechanism that acts as an essential filter for our complex sensory environment. Convergent evidence indicates neural habituation is disrupted in both early and chronic stages of schizophrenia, with deficits co-occurring in brain regions that show inhibitory dysfunction. As inhibitory deficits have been proposed to contribute to the onset and progression of illness, habituation may be an important treatment target. However, a crucial first step is clarifying whether habituation deficits progress with illness. In the present study, we measured neural habituation in 138 participants (70 early psychosis patients (<2 years of illness), 68 healthy controls), with 108 participants assessed longitudinally at both baseline and 2-year follow-up. At follow-up, all early psychosis patients met criteria for a schizophrenia spectrum disorder (i.e., schizophreniform disorder, schizophrenia, schizoaffective disorder). Habituation slopes (i.e., rate of fMRI signal change) to repeated images were computed for the anterior hippocampus, occipital cortex, and the fusiform face area. Habituation slopes were entered into a linear mixed model to test for effects of group and time by region. We found that early psychosis patients showed habituation deficits relative to healthy control participants across brain regions, and that these deficits were maintained, but did not worsen, over two years. These results suggest a stable period of habituation deficits in the early stage of schizophrenia.
- 11 October 2020
- Published by Elsevier in Psychiatry Research
- Vol. 294, 113508
Relational memory in the early stage of psychotic bipolar disorder
- 11 October 2020
- Published by Elsevier in Psychiatry Research
- Vol. 294, 113508
Relational memory in the early stage of psychotic bipolar disorder
- 28 July 2020
- Published by Elsevier in Schizophrenia Research
- Vol. 223, 179-185
Habituation during encoding: A new approach to the evaluation of memory deficits in schizophrenia
- 28 July 2020
- Published by Elsevier in Schizophrenia Research
- Vol. 223, 179-185
Habituation during encoding: A new approach to the evaluation of memory deficits in schizophrenia
- 1 May 2020
- Published by Elsevier in Psychiatry Research
- Vol. 287, 112910
Visual exploration differences during relational memory encoding in early psychosis
- 1 May 2020
- Published by Elsevier in Psychiatry Research
- Vol. 287, 112910
Visual exploration differences during relational memory encoding in early psychosis